P73

Protein-coding gene in the species Homo sapiens
TP73
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

4GUQ, 1COK, 1DXS, 2KBY, 2MPS, 2WQI, 2WQJ, 2WTT, 2XWC, 3VD0, 3VD1, 3VD2, 4A63, 4G82, 4G83, 4GUO

Identifiers
AliasesTP73, P73, tumor protein p73, CILD47
External IDsOMIM: 601990; MGI: 1336991; HomoloGene: 3960; GeneCards: TP73; OMA:TP73 - orthologs
Gene location (Human)
Chromosome 1 (human)
Chr.Chromosome 1 (human)[1]
Chromosome 1 (human)
Genomic location for TP73
Genomic location for TP73
Band1p36.32Start3,652,516 bp[1]
End3,736,201 bp[1]
Gene location (Mouse)
Chromosome 4 (mouse)
Chr.Chromosome 4 (mouse)[2]
Chromosome 4 (mouse)
Genomic location for TP73
Genomic location for TP73
Band4 E2|4 83.79 cMStart154,140,706 bp[2]
End154,224,665 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • right uterine tube

  • bronchial epithelial cell

  • cerebellar hemisphere

  • skin of abdomen

  • minor salivary glands

  • bone marrow cells

  • vagina

  • prostate

  • right lung

  • thymus
Top expressed in
  • lip

  • secondary oocyte

  • Jacobson's organ

  • neuron

  • esophagus

  • hair follicle

  • skin of back

  • right lung lobe

  • skin of abdomen

  • cerebellar cortex
More reference expression data
BioGPS
More reference expression data
Gene ontology
Molecular function
  • DNA binding
  • sequence-specific DNA binding
  • DNA-binding transcription activator activity, RNA polymerase II-specific
  • transcription factor binding
  • chromatin binding
  • metal ion binding
  • RNA polymerase II cis-regulatory region sequence-specific DNA binding
  • damaged DNA binding
  • protein binding
  • identical protein binding
  • protein kinase binding
  • p53 binding
  • DNA-binding transcription factor activity
  • MDM2/MDM4 family protein binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
Cellular component
  • cytoplasm
  • Golgi apparatus
  • intracellular membrane-bounded organelle
  • transcription regulator complex
  • cell junction
  • chromatin
  • nucleus
  • mitochondrion
  • nucleoplasm
  • cytosol
Biological process
  • negative regulation of neuron apoptotic process
  • positive regulation of oligodendrocyte differentiation
  • intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
  • regulation of transcription, DNA-templated
  • negative regulation of neuron differentiation
  • kidney development
  • cellular response to UV
  • negative regulation of transcription by RNA polymerase II
  • protein tetramerization
  • transcription, DNA-templated
  • cellular response to DNA damage stimulus
  • mitotic G1 DNA damage checkpoint signaling
  • response to organonitrogen compound
  • intrinsic apoptotic signaling pathway in response to DNA damage
  • regulation of mitotic cell cycle
  • positive regulation of apoptotic process
  • regulation of gene expression
  • DNA mismatch repair
  • cell cycle
  • negative regulation of cardiac muscle cell proliferation
  • viral process
  • negative regulation of JUN kinase activity
  • response to gamma radiation
  • response to X-ray
  • positive regulation of transcription by RNA polymerase II
  • DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator
  • negative regulation of cell population proliferation
  • apoptotic process
  • regulation of signal transduction by p53 class mediator
  • transcription by RNA polymerase II
  • regulation of apoptotic process
  • positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
  • positive regulation of transcription, DNA-templated
  • regulation of hematopoietic stem cell differentiation
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

7161

22062

Ensembl

ENSG00000078900

ENSMUSG00000029026

UniProt

O15350

Q9JJP2

RefSeq (mRNA)
NM_001126240
NM_001126241
NM_001126242
NM_001204184
NM_001204185

NM_001204186
NM_001204187
NM_001204188
NM_001204189
NM_001204190
NM_001204191
NM_001204192
NM_005427

NM_001126330
NM_001126331
NM_011642

RefSeq (protein)
NP_001119712
NP_001119713
NP_001119714
NP_001191113
NP_001191114

NP_001191115
NP_001191116
NP_001191117
NP_001191118
NP_001191119
NP_001191120
NP_001191121
NP_005418

NP_001119802
NP_001119803
NP_035772

Location (UCSC)Chr 1: 3.65 – 3.74 MbChr 4: 154.14 – 154.22 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

p73 is a protein related to the p53 tumor protein. Because of its structural resemblance to p53, it has also been considered a tumor suppressor. It is involved in cell cycle regulation, and induction of apoptosis. Like p53, p73 is characterized by the presence of different isoforms of the protein. This is explained by splice variants, and an alternative promoter in the DNA sequence.

p73, also known as tumor protein 73 (TP73), protein was the first identified homologue of the tumor suppressor gene, p53. Like p53, p73 has several variants. It is expressed as distinct forms differing at either at the C- or the N-terminus. Currently, six different C-terminus splicing variants have been found in normal cells. The p73 gene encodes a protein with a significant sequence homology and a functional similarity with the tumor suppressor p53. The over-expression of p73 in cultured cells promotes a growth arrest and/or apoptosis similarly to p53.

The p73 gene has been mapped to a chromosome region (1p36. 2-3) a locus commonly deleted in various tumor entities and human cancers. Similar to p53 the protein product of p73 induces cell cycle arrest or apoptosis, hence its classification as a tumor suppressor. However unlike its counterpart, p73 is infrequently mutated in cancers. Perhaps, even more shocking is the fact that p73 – deficient mice do not show a tumorigenic phenotype. A deficiency of p53 almost certainly leads to unchecked cell proliferation and is noted in 60% of cancers.

Analyses of many tumors typically found in humans including breast and ovarian cancer show a high expression of p73 when compared to normal tissues in corresponding areas. Adenoviruses that cause cellular transformations have also been found to result in increased p73 expression. Furthermore, recent finding are suggesting that over-expression of transcription factors involved in cell cycle regulation and synthesis of DNA in mammalian cells (e.g.: E2F-1) induces the expression of p73. Many researchers believe that these results imply that p73 may not be a tumor suppressor but rather an oncoprotein. Some suggest that the TP73 locus encodes both a tumor suppressor (TAp73) and a putative oncogene (ΔNp73). This is a strong theory and causes much confusion, as it is unknown which of the two p73 variants is over-expressed and ultimately plays a role in tumorigenesis.

Genes of the p53 family are known to be complex. The viral oncoproteins (e.g. Adenovirus E1B) that efficiently inhibit p53 function are unable to inactivate p73, and those that seem to inhibit p73 have no effect on p53.

Debate persists about the exact function of p73. Recently it has been reported that p73 is enriched in the nervous system and that the p73-deficient mice, which do not exhibit an increased susceptibility to spontaneous tumorigenesis, have neurological and immunological defects. These results have been expanded and it has also been shown that p73 is present in early stages of neurological development and neuronal apoptosis by blocking the proapoptotic function of p53. This strongly implicates p73 as playing a large role in cellular differentiation.

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000078900 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000029026 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

External links

  • A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73α protein with a dominant-negative function
  • TP73+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  • Overview of all the structural information available in the PDB for UniProt: O15350 (Tumor protein p73) at the PDBe-KB.

Further reading

  • Kaghad M, Bonnet H, Yang A, et al. (August 1997). "Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers". Cell. 90 (4): 809–19. doi:10.1016/S0092-8674(00)80540-1. PMID 9288759. S2CID 16867357.
  • Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G (May 2000). "The p53/p63/p73 family of transcription factors: overlapping and distinct functions". J. Cell Sci. 113 (10): 1661–70. doi:10.1242/jcs.113.10.1661. PMID 10769197.
  • Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD (July 2000). "An anti-apoptotic role for the p53 family member, p73, during developmental neuron death". Science. 289 (5477): 304–6. Bibcode:2000Sci...289..304P. doi:10.1126/science.289.5477.304. PMID 10894779.
  • Yang A, Walker N, Bronson R, et al. (March 2000). "p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours". Nature. 404 (6773): 99–103. Bibcode:2000Natur.404...99Y. doi:10.1038/35003607. PMID 10716451. S2CID 4428591.
  • Kaelin WG (1999). "The emerging p53 gene family". J. Natl. Cancer Inst. 91 (7): 594–8. doi:10.1093/jnci/91.7.594. PMID 10203277.
  • Davis PK, Dowdy SF (2001). "p73". Int. J. Biochem. Cell Biol. 33 (10): 935–9. doi:10.1016/S1357-2725(01)00073-5. PMID 11470228.
  • Salomoni P, Pandolfi PP (2002). "The role of PML in tumor suppression". Cell. 108 (2): 165–70. doi:10.1016/S0092-8674(02)00626-8. PMID 11832207. S2CID 1867299.
  • Melino G (2004). "p73, the "assistant" guardian of the genome?". Ann. N. Y. Acad. Sci. 1010: 9–15. doi:10.1196/annals.1299.002. PMID 15033688. S2CID 2937853.
  • Jacobs WB, Walsh GS, Miller FD (2005). "Neuronal survival and p73/p63/p53: a family affair". The Neuroscientist. 10 (5): 443–55. doi:10.1177/1073858404263456. PMID 15359011. S2CID 39702742.
  • Rossi M, Sayan AE, Terrinoni A, et al. (2005). "Mechanism of induction of apoptosis by p73 and its relevance to neuroblastoma biology". Ann. N. Y. Acad. Sci. 1028: 143–9. doi:10.1196/annals.1322.015. PMID 15650240. S2CID 3103009.
  • Dobbelstein M, Strano S, Roth J, Blandino G (2005). "p73-induced apoptosis: a question of compartments and cooperation". Biochem. Biophys. Res. Commun. 331 (3): 688–93. doi:10.1016/j.bbrc.2005.03.155. PMID 15865923.
  • Ramadan S, Terrinoni A, Catani MV, et al. (2005). "p73 induces apoptosis by different mechanisms". Biochem. Biophys. Res. Commun. 331 (3): 713–7. doi:10.1016/j.bbrc.2005.03.156. PMID 15865927.
  • Harms KL, Chen X (2006). "p19ras brings a new twist to the regulation of p73 by Mdm2". Sci. STKE. 2006 (337): pe24. doi:10.1126/stke.3372006pe24. PMID 16738062. S2CID 22706614.
  • Marabese M, Vikhanskaya F, Broggini M (2007). "p73: a chiaroscuro gene in cancer". Eur. J. Cancer. 43 (9): 1361–72. doi:10.1016/j.ejca.2007.01.042. PMID 17428654.
  • Levy D, Adamovich Y, Reuven N, Shaul Y (2007). "The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73". Cell Death and Differentiation. 14 (4): 743–51. doi:10.1038/sj.cdd.4402063. PMID 17110958.
  • v
  • t
  • e
  • 1cok: STRUCTURE OF THE C-TERMINAL DOMAIN OF P73
    1cok: STRUCTURE OF THE C-TERMINAL DOMAIN OF P73
  • 1dxs: CRYSTAL STRUCTURE OF THE C-TERMINAL STERILE ALPHA MOTIF (SAM) DOMAIN OF HUMAN P73 ALPHA SPLICE VARIANT
    1dxs: CRYSTAL STRUCTURE OF THE C-TERMINAL STERILE ALPHA MOTIF (SAM) DOMAIN OF HUMAN P73 ALPHA SPLICE VARIANT
  • v
  • t
  • e
Ligand
Growth factors
ONCO
Receptor
Wnt signaling pathway
TSP
  • CDH1
Hedgehog signaling pathway
TSP
TGF beta signaling pathway
TSP
Receptor tyrosine kinase
ONCO
JAK-STAT signaling pathway
ONCO
Intracellular signaling P+Ps
Wnt signaling pathway
ONCO
TSP
TGF beta signaling pathway
TSP
Akt/PKB signaling pathway
ONCO
TSP
  • PTEN
Hippo signaling pathway
TSP
  • Neurofibromin 2/Merlin
MAPK/ERK pathway
ONCO
TSP
Other/unknown
ONCO
TSP
Nucleus
Cell cycle
ONCO
TSP
DNA repair/Fanconi
TSP
Ubiquitin ligase
ONCO
TSP
Transcription factor
ONCO
TSP
Mitochondrion
Apoptosis inhibitor
Other/ungrouped